Bavarian Nordic’s Jynneos® has been approved as a vaccine for individuals 18 years of age and older who are determined to be at high risk for monkeypox infection.

• Recommended dosing is two doses (0.5 mL each) 4 weeks apart, both taken subcutaneously.
• The FDA issued an emergency use authorization (EUA) for Jynneos.